Bio 600 billion to 350 billion IPO

Money Today
Molrinda 1 trillion investment in biotechnology companies this year
. Article inputs 2015-08-13 14:16 0
[Money Today gimmyeongryong News] [Bio 600 billion to 350 billion IPO, the company expected capital inflows into venture capital;
Body image

This year biotechnology companies are expected to raise funds of about 1 trillion won through venture investment and IPO (IPO). This means that if these funds will be invested in research and development (R & D) in the largest ever bio-industry is expected to be an opportunity to grow one step.

Benche 13 days this year, according to BNK Securities and Capital Association July biotechnology companies IPO IPO funds totaled 332.3 billion won in total. The 142% increase in full-year Pharmaceuticals & biotechnology companies IPO funding levels than 136.9 billion won. Alarm pharmaceutical, jenopokeoseu, core systems, pepteuron, Pharma Products etc. Research has been listed on the stock market this year Liege success.

This year there are a publicly traded company is also waiting in line. Jen care (Cosmeceuticals drugs, growth factors) are expected to raise funds of about 140 billion won over the KOSDAQ jiksangjang year. Dino and (antibody drug development, medical device manufacturing) tijen this (cancer diagnostic kit) yuaenahyi (medical devices for orthopedic surgeons) and has passed the gisulseong assessment, submitted a bill for the public and are seeking a special gisulseong it traded this year. The size of the IPO funds on the basis of the hope gongmoga is around 230 billion won.

The kids camp listed in the Conex (diabetic retinopathy treatment, cervical cancer vaccine) MG Med (genetic diseases molecular diagnostics), also aims at the total IPO size previously listed in KOSDAQ is expected to be 340 billion won. Given this scale of IPO financing biotechnology companies this year is expected to reach 600 billion won.

Choejonggyeong BNK Securities Researchers analyzed that "because the regulations and requirements for the IPO significantly mitigate pas" "Last year, biotech companies are listed in gisulseong exemption, but only one third place this year, has already been traded," said.

"The progress of the New Testament and early clinical development costs invested a lot of biotechnology companies are entering successively traded on the KOSDAQ market through special institutions" and "publicly traded company's stock price has already exceeded the gongmoga of publicly traded biotechnology companies to promote even now is likely to be traded successfully, "he added.

Investment in bio-venture companies also growing trend. Last year, venture capital investment was about 292.8 billion won for biotechnology. This is a 100% increase in value than the 146.3 billion won in 2013. New this year is expected to venture capital investments in biotechnology surpass 3500 billion.

Hwangmansun Korea Investment Partners Managing Director "In the past, this was a case of domestic profitability than companies that have technology companies are more focused I am." "In Europe and the United States and appreciates the value of companies with new drug candidates," he said He said. He said, "Now, this leading-edge company that develops new drugs and medical devices began to receive attention in Korea," said "there are limitations, such as investment conditions are improving for the government to come forward to foster bio-industry development fund," he added.

Department of Health and Human Services is currently a total of 100 billion won sizes (20 billion won investment and Welfare), 1350 million (20 billion won investment and Welfare) invests joseonghae the size of the pharmaceutical industry development fund. Another 150 billion won (30 billion won investment and Welfare) plans to raise additional funds in the scale.

Bio-industry is expected to be established through the research and development funding. Yimyeongjae kids camp director of "technology transfer overseas until they are done for the drug candidate is required funding for research and development," he said, "If long-term funding is provided through financing company can continue to develop based on the is expected to be prepared, "he said.
[The rich are so "Julia investment notes'] changed the lives of the CEO 'best advice my life' [change my life political news' the 300 '] [The wonder big deal? Look at the 'alrya ZOOM' ~] [~ Racing dazzling special place;

Gimmyeongryong reporters dragong@mt.co.kr